Gemcitabine Induces Microvesicle Particle Release in a Platelet-Activating Factor-Receptor-Dependent Manner via Modulation of the MAPK Pathway in Pancreatic Cancer Cells. [electronic resource]
Producer: 20190403ISSN:- 1422-0067
- Antimetabolites, Antineoplastic -- pharmacology
- Cell Line, Tumor
- Cell-Derived Microparticles -- metabolism
- Deoxycytidine -- analogs & derivatives
- Humans
- MAP Kinase Signaling System -- drug effects
- Pancreatic Neoplasms -- metabolism
- Platelet Membrane Glycoproteins -- agonists
- Receptors, G-Protein-Coupled -- agonists
- Sphingomyelin Phosphodiesterase -- metabolism
- Gemcitabine
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.